India Not to Allow Clinical Trial of Russia’s Sputnik V Vaccine For Coronavirus
Even though Russia claims to be the first country that has developed an effective vaccine for the COVID-19, its Sputnik V vaccine will not be allowed for human trials in India. The Drugs Controller General of India refused the third phase trial of Russia’s Sputnik V proposed by pharma company Dr Reddy’s laboratories.
The Indian authority believes that the early trials of the Russian vaccine were conducted on a small group of population.
Dr Reddy’s Lab was planning to join hands with the Russian Direct Investment Fund (RDIF) and start the clinical trials of the Sputnik V vaccine. The pharma company was also eying the distribution rights of the Russian vaccine in India.
The experts worldwide have raised concerns over the Sputnik V vaccine’s safety as it was developed in a short time.
Union health minister Harsh Vardhan announced that India has not refused Dr Reddy’s to go ahead with the trial of the Russian vaccine.
In Russia, the third phase of the Sputnik V vaccine is being conducted on as many as 40,000 people since September 1.
“After detailed deliberation, the committee recommended that the firm should follow the regulatory requirements and conduct phase 2/3 trial in the country with proper monitoring for humoral and cell mediated immune response,” the committee that looked into Dr Reddy’s proposal stated.
Subscribe for newsletter
* You will receive the latest news and updates